MYC and cancer: Although we have not specifically investigated these pathways in the present study, it is plausible that targeting AURKA in CDDP‐resistant cancer models may induce cancer cell death not only through the suppression of eIF4E‐c‐MYC‐HDM2, but also through reversing these signaling effects.